Commentary In April 2019 the Houston Chronicle, in collaboration with Science magazine, published an article documenting an extensive FBI investigation into communist China’s infiltration of major U.S. medical research institutions. One target was the MD Anderson Cancer Center, located in Houston, Texas. Emory University’s medical research institute (Atlanta, Georgia) was also a Chinese bullseye. In June 2019 the National Institutes of Health (NIH) told U.S. Senate investigators that employees at 61 research institutions may have withheld information about undisclosed relations with foreign governments—meaning undisclosed financial and personal relations that violated strict NIH funding policies. The admission belatedly confirmed a 2018 letter by then-NIH Director Francis Collins warning research institutions that NIH suspected “foreign entities have mounted systematic programs to influence NIH researchers and peer reviewers.” Influence is certainly one of Beijing’s objectives. Several notches above mere influence is acquisition of medical data, and in the case of MD Anderson and …